p53 Overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 709-715

  Chang, Fuju ^a,c   Syrjänen, Stina ^a,b   Wang, Lijuan ^a,c   Shen, Qiong ^c   Syrjänen, Kari ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

HPV; Hybridization; Oesophageal carcinoma; p53

Indexed keywords

PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER TISSUE; CARCINOMA IN SITU; CHINA; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INVASIVE CARCINOMA; LYMPH NODE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHINA; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1842335720     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Chang F, Syrjänen S, Wang and Syrjänen K: Infectious agents in the etiology of esophageal cancer. Gastroenterology 103: 1136-1148, 1992.
2. Syrjänen KJ: Histological changea identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 52: 283-292, 1982.
3. Chang F, Syrjänen S, Shen Q, Ji H and Syrjänen K: Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int J Cancer 45: 21-25, 1990.
4. Williamson AI, Jaskiesicz K and Gunning A: The detection of human papillomavirus in oesophagenl lesions. Anticancer Res 11: 263-266, 1991.
5. Benamouzig R, Pigot F, Quirogn G, Dalidire P, Chaussade S, Catalan F and Couturíer D: Human papillomavirus infection in esophageal squamous-coll carcinoma in Western countries. Int J Cancer 50: 549-552, 1992.
6. Toh Y, Kuwuno H, Tanaka S, Baba K, Matsuda H, Sugimachi K and Mori R: Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 70: 2234-2238, 1992.
7. Chang F, Syrjänen S, Shen Q, Wang L, Wang D and Syrjänen K: Human papillomavirus (HPV) involvement in esophageal precancer lesions und squamous cell carcinomas as evidenced by microscopy and different DNA-techniques. Scand J Gastroenterol 27: 553-563, 1992.
8. Chang F, Syrjänen S, Shen Q, Wang L and Syrjänen K: Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization. Cancer 72: 2525-2530, 1993.
9. Furihuta M, Ohtsuki Y, Ogoshi S, Takahashi A. Tamiya T and Ogata T: Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 54: 226-230, 1993.
10. Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ and Rustgi AK: Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 107: 128-136, 1994.
11. Chen B, Yin H and Dhurandhar N: Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers, Hum Pathol 25: 920-923, 1994.
12. Cooper K, Taylor L and Govind S: Human papillomavirus DNA in oesophageal carcinomas in South Africa. J Pathol 175: 273-277, 1995.
13. Fidalgo PO, Cravo ML, Chaves PP, Leitao CN and Mira FC: High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa: assessment by polymerase chain reaction. Cancer 76: 1522-1528, 1995.
14. Nishihira T, Hashimoto Y, Katayama M, Mori S and Kuroki T: Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 119:441-449, 1993.
15. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ and Meltzer SJ: Loss of heterozygnsity involves multiple tumor suppressor genes in human esophageal cancers, Cancer Res 52: 6525-6530, 1992.
16. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Ishida K, Saito K and Satodate R: Aberrations of tumor-suppressor genes (p53, apc, mcc and Rb) in esophageal squamous-cell carcinoma. Int J Cancer 57: 21-25, 1994.
17. Levine AJ: The tumor suppressor genes, Annu Rev Biochem 62: 623-651, 1993.
18. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
19. Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
20. Chang F, Syrjänen S, Tervahauta A and Syrjänen K: Tumorigenesis associated with the p53 tumor suppressor gene. Br J Cancer 68: 653-661, 1993.
21. Chang F, Syrjänen S, Kurvinen K and Syrjänen K: The p53 tumor suppressor gene as a common cellular target In human carcinogenesis. Am J Gastroenterol 88: 174-186, 1993.
22. Hollstein MC, Metcalf RA, Welsh JA, Montesano R and Harris CC: Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 87: 9958-9961, 1990.
23. Hollstein MC, Perl L, Mandard AM, Welsh JA, Montesano R, Metcalf RA, Bak M and Harris CC Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 51: 4102-4106, 1991.
24. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP and Harris CC: Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogcne 6: 1779-1784, 1991.
25. Imazeki F, Omata M, Nose H, Ohto M and Isono K: p53 gene mutations in gastric and esophageal cancers. Gastroenterology 103: 892-896, 1992.
26. Audrezet MP, Robaszkiewicz M, Mercier B, Nousbaum JB, Bail JP, Hardy E, Volant A, Lozac'h P, Charles JF, Goueron H and Ferec C: Tp53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res 53: 5745-5749, 1993.
27. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B and Roth JA: p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 51: 4495-4499, 1991.
28. Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF and Zou ZQ: Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res 53: 1889-1894, 1993.
29. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY and Yang CS: p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 54: 4342-4346, 1994.
30. Hall PA and Lane DP: p53 in tumour pathology: can we trust immunohistochemistry? revisited. J Pathol 172: 1-4, 1994.
31. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howely PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degeneration of p53. Cell 63: 1129-1136, 1990.
32. Qiu SL and Yang GR: Precursor lesions of esophageal cancer in high-risk populations in Henan province, China. Cancer 62: 551-557, 1988.
33. Wang LD, Hong JY, Qiu SL, Gao H and Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53: 1783-1787, 1993.
34. Shimaya K, Shiozaki H, Inoue M, Tahara H, Monden T, Shimano T and Mori T: Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch A Pathol Anat Histopathol 422: 271-276, 1993.
35. Wang DY, Xiang W, Tanaka M, Li XR, Li JL, Shen Q, Sugimura H and Kino I: High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 74: 3089-3096, 1994.
36. Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL and Yang CS: Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastriccardia carcinogenesis. Int J Cancer 59: 514-519, 1994.
37. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R and Gabbert H: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74: 2218-2223, 1994.
38. Parenti AR, Rugge M, Frizera E, Ruol A, Noventa F, Ancona E, Ninfo V: p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 19: 1418-1422, 1995.
39. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP and Harris CC: p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 52: 6092-6097, 1992.
40. Esteve A, Lehman T, Jiang W, Weinstein IB, Harris CC, Ruol A, Peracchia A, Montesano R and Hollstein M: Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog 8: 306-311, 1993.
41. Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T and Ishizaki K: Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 53: 846-850, 1993.
42. Iggo R, Gatter K, Bartek J, Lane D and Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679, 1990.
43. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC and Berchuck A: Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51: 2979-2984, 1991.
44. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH and Smith HS: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992.
45. Crook T, Wrede D and Vousden KH: p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6: 873-875, 1991.
46. Scheffner M, Munger K, Byrne JC and Howely PM: The state of the p53 and retinoblastoma genes in human cervical cell lines. Proc Natl Acad Sci USA 88: 5523-5527, 1991.
47. Iwasaka T, Oh-Uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K, Fukuyama K, Hori K and Sugimori H: Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Gynecol Oncol 48: 104-109, 1993.
48. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ and Vuosden KH: Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 339: 1070-1073, 1992.
49. Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N and Fujita Y: High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53: 4823-4827, 1993.
50. Snijders PJ, Steenbergen RD, Top B, Scott SD, Meijer CJ and Walboomers JM: Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 75: 2769-2775, 1994.
51. Lee NK, Ye YW, Chen J, Li X, Waber PG and Nisen PD: p53, retinoblastoma. and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Arch Otolarygol Head Neck Surg 119: 1125-1131, 1993.
52. Chang F, Syrjänen S, Tervahauta A, Kurvinen K, Wang L and Syrjänen K: Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Br J Cancer 70: 346-351, 1994.
53. Cooper K: p53 mutations in human papillomavirus-associated oesophageal squamous cell carcinoma (letter). Br J Cancer 72: 1337, 1995.
54. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
55. zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13, 1991.